Nonalcoholic fatty liver disease activity score and mortality: Imperfect but not insignificant
Veeral Ajmera – 30 October 2015
Freshwater clam extract supplement‐induced acute cholestasis
Hiroaki Yokomori, Hitoshi Yamazaki, Masaya Oda – 30 October 2015
Categorization of drugs implicated in causing liver injury: Critical assessment based on published case reports
Einar S. Björnsson, Jay H. Hoofnagle – 30 October 2015 – An important element in assessing causality in drug‐induced liver injury is whether the implicated agent is known to cause hepatotoxicity. We classified drugs into categories based on the number of published reports of convincingly documented, clinically apparent, idiosyncratic liver injury. Drugs described in the website LiverTox (http://livertox.nih.gov) were classified into five categories based on the number of published cases (category A, ≥50; category B, 12‐49; category C, 4‐11; category D, 1‐3; category E, none).
DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection
Maria Antonella Burza, Benedetta Maria Motta, Rosellina Margherita Mancina, Piero Pingitore, Carlo Pirazzi, Saverio Massimo Lepore, Rocco Spagnuolo, Patrizia Doldo, Cristina Russo, Veronica Lazzaro, Janett Fischer, Thomas Berg, Alessio Aghemo, Cristina Cheroni, Raffaele De Francesco, Silvia Fargion, Massimo Colombo, Christian Datz, Felix Stickel, Luca Valenti, Stefano Romeo – 30 October 2015 – Chronic hepatitis C virus (HCV) infection may progress to cirrhosis and hepatocellular carcinoma (HCC).
Reply
Mattias Ekstedt, Hannes Hagström, Patrik Nasr, Mats Fredrikson, Per Stal, Stergios Kechagias, Rolf Hultcrantz – 30 October 2015
Clinical characteristics and outcomes of pyogenic vertebral osteomyelitis in patients with cirrhosis
Seong Yeon Park, Ki‐Ho Park, Oh‐Hyun Cho, Yu‐Mi Lee, Sang‐Ho Choi, Mi Suk Lee – 30 October 2015
Hemophilia B acquired through liver transplantation
Denise Menezes Brunetta, Fabiana Aguiar Carneiro‐Silva, João Batista Marinho Vasconcelos, Rosângela de Albuquerque Ribeiro, Denissa Ferreira Gomes Mesquita, Gustavo Rego Coelho, Fernando Barroso‐Duarte, José Huygens Parente Garcia – 29 October 2015
Impact of body mass index on posttransplant outcomes reexamined
Kiran M. Bambha, Jennifer L. Dodge, Jane Gralla, Scott W. Biggins – 29 October 2015
Efficacy and cost‐effectiveness of voriconazole prophylaxis for prevention of invasive aspergillosis in high‐risk liver transplant recipients
Julius Balogh, Sherilyn Gordon Burroughs, Maha Boktour, Samir Patel, Ashish Saharia, Robert A. Ochoa, Robert McFadden, David W. Victor, Victor Ankoma‐Sey, Joseph Galati, Howard P. Monsour, Victor Fainstein, Xian C. Li, Kevin A. Grimes, A. Osama Gaber, Thomas Aloia, R. Mark Ghobrial – 29 October 2015 – Aspergillus infection remains a significant and deadly complication after liver transplantation (LT).
Persistent hepatitis C viral replication despite priming of functional CD8+ T cells by combined therapy with a vaccine and a direct‐acting antiviral
Benoit Callendret, Heather B. Eccleston, William Satterfield, Stefania Capone, Antonella Folgori, Riccardo Cortese, Alfredo Nicosia, Christopher M. Walker – 29 October 2015 – Exhaustion of antiviral CD8+ T cells contributes to persistence of hepatitis C viral (HCV) infection. This immune response has proved difficult to restore by therapeutic vaccination, even when HCV replication is suppressed using antiviral regimens containing type I interferon.